Hot Pursuit     18-Dec-23
Zydus Lifesciences Ltd spurts 4%, up for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The stock is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma.

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 21449.3. The Sensex is at 71428.87, down 0.08%. Zydus Lifesciences Ltd has gained around 5.62% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 3.68% in last one month and is currently quoting at 16179.8, up 1.29% on the day. The volume in the stock stood at 49.43 lakh shares today, compared to the daily average of 11.55 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 674.05, up 3.96% on the day. Zydus Lifesciences Ltd is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma index.

The PE of the stock is 26.24 based on TTM earnings ending September 23.

Previous News
  Zydus Life gets tentative USFDA nod for hypertension drugs
 ( Hot Pursuit - 14-Jun-24   12:34 )
  Zydus receives USFDA approval for Zinc Sulfate Injection
 ( Corporate News - 24-Aug-23   11:36 )
  Zydus SEZ-2 units at Ahmedabad clears USFDA inspection
 ( Corporate News - 08-Jul-23   10:46 )
  Sentynl, a Zydus company, acquires Zokinvy® (Lonafarnib)
 ( Corporate News - 04-May-24   10:42 )
  Zydus Life gains on receiving USFDA nod for Clindamycin Phosphate Gel
 ( Hot Pursuit - 21-Sep-23   09:29 )
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus to initiate Phase I clinical study of a novel Anti-PCSK9 candidate
 ( Corporate News - 29-Sep-23   15:10 )
  Zydus Life receives USFDA approval for Zinc Sulfate Injection
 ( Hot Pursuit - 24-Aug-23   11:50 )
  Zydus receives USFDA approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension
 ( Corporate News - 08-Jun-23   14:43 )
  USFDA conducts inspection of Zydus' API site at Changodar, Ahmedabad
 ( Corporate News - 22-Dec-23   19:54 )
  Zydus Life Ahmedabad facility clears USFDA inspection
 ( Hot Pursuit - 08-Jul-23   11:47 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top